Stock Updates

Is this Large Market Cap Stock target price reasonable for China Biologic Products, Inc. (NASDAQ:CBPO)?

The company in question is, China Biologic Products, Inc. (NASDAQ:CBPO) currently with a stock price of 116.86 (-1.49% today). The market cap for China Biologic Products, Inc. is 3212.5, and is in the sector Healthcare, and Biotechnology industry. The target price for China Biologic Products, Inc. is 150.29. Currently China Biologic Products, Inc. is trading with a P/E of 34.28, and a forward P/E of 22.93. Average volume for China Biologic Products, Inc. is 218.05 and so far today it is 48690.

Performance in the last year for China Biologic Products, Inc. has been 18.63%. For EPS growth, China Biologic Products, Inc. has seen a growth of 20.60%, and is looking to grow in the next year to 19.39%. More long term stats show that EPS growth has been 20.20% over the last five years and could be 18.15% for the next five years. China Biologic Products, Inc. has seen sales growth quarter over quarter at -38.80%, with EPS growth quarter over quarter at -39.40%. The 20-day simple moving average is -3.02%, with the 200-day simple moving average coming to -0.65%.

Since the IPO date for China Biologic Products, Inc. on the 1/29/2008, China Biologic Products, Inc. has seen performance year to date to be -16.73%. With China Biologic Products, Inc. trading at 116.86, the dividend yield is *TBA, and the EPS is 3.46.

So could China Biologic Products, Inc., be undervalued? Well as said before P/E is 34.28. The PEG is 1.89, P/S is 9.92 and the P/B is at 7.16. The P/cash is 15.75, with P/free cash flow at 43.65.

China Biologic Products, Inc. ability to deal with debt shows that the current ratio is 6.3, and the quick ratio is 4.2. This is with long term debt/equity at 0, and total debt/equity at 0.

In terms of margins, China Biologic Products, Inc. has a gross margin of 62.80%, an operating margin of 42.80% and a profit margin of 28.90%.Payout ratio for China Biologic Products, Inc. is 0.00%. Return on assets come to 16.60% with return on investment coming to 29.20%.

Insider ownership for China Biologic Products, Inc., is at 1.70% and institutional ownership comes to 76.30%. Outstanding shares are at 27.08. While shares float is 22.16. The float short is currently 2.97%, and short ratio is 3.02.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment